why choose us

First received: January 02, 2024

Clinical Trial: Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Melanoma

Study Type: OBSERVATIONAL


Official Title: Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy

Brief Summary: Background of the study:Immune checkpoint inhibitors (ICIs) are widely used as treatment for multiple cancer types and the number of patients with longterm disease control after ICIs is increasing.However, the use of ICIs is associated with adverse events (AEs) which can have a negative impact on quality of life (QoL).These AEs include oral manifestations, like alterations in taste and smell, xerostomia, and oral mucosal disorders, and could lead to unwanted weight loss.However, the characteristics of taste and…

Read more